Gordon J. Brooks - 15 Jul 2024 Form 3 Insider Report for ELI LILLY & Co (LLY)

Role: Interim CFO, Group VP
Signature: /s/ Jonathan Groff for Gordon J. Brooks, pursuant to authorization attached
Issuer symbol: LLY
Transactions as of: 15 Jul 2024
Net transactions value: $0
Form type: 3
Filing time: 19 Jul 2024, 16:16:12 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LLY	Common Stock						12,403	15 Jul 2024	Direct
holding	LLY	Common Stock						3,694	15 Jul 2024	401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LLY	Restricted Stock Unit							15 Jul 2024	Common Stock	3,067		Direct	F1
holding	LLY	Restricted Stock Unit							15 Jul 2024	Common Stock	276		Direct	F1
holding	LLY	Restricted Stock Unit							15 Jul 2024	Common Stock	4,600		Direct	F1
holding	LLY	Restricted Stock Unit							15 Jul 2024	Common Stock	278		Direct	F1
holding	LLY	Phantom Stock							15 Jul 2024	Common Stock	741		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
F2	Represent benefits under Eli Lilly and Company's excess savings plan distributable in cash upon the reporting person's retirement or other termination of service.